title: In vivo decreased dopamine transporter uptake in corticobasal degeneration presenting with primary progressive aphasia without parkinsonism.
authors.affiliation: Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Department, Hospital Clínic, Barcelona, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Gil-Navarro
authors.forename: E
authors.initials: E
authors.lastname: Gelpi
authors.forename: F
authors.initials: F
authors.lastname: Lomeña
authors.forename: N
authors.initials: N
authors.lastname: Montagut
authors.forename: A
authors.initials: A
authors.lastname: Lladó
authors.forename: J L
authors.initials: JL
authors.lastname: Molinuevo
authors.forename: R
authors.initials: R
authors.lastname: Sánchez-Valle
mesh_terms: D001284:Atrophy / Q000378:metabolism / Q000473:pathology; D001479:Basal Ganglia / Q000378:metabolism / Q000473:pathology; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology; D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D057178:Primary Progressive Nonfluent Aphasia / Q000175:diagnosis* / Q000209:etiology; D024801:Tauopathies / Q000150:complications / Q000175:diagnosis*
chemical_list: D050483:Dopamine Plasma Membrane Transport Proteins
keywords: 123I-FP-CIT SPECT; corticobasal degeneration; primary progressive aphasia; primary progressive nonfluent aphasia; tauopathy